The ASC fully supports the use of HPV vaccines. We encourage all women -- even if vaccinated -- to continue regular Pap tests screening for cervical cancer.
The types of HPV that the vaccine works against are responsible for only 70% of the cases of cervical cancer, and no one knows how long the immunity provided by the vaccine will last.
Regularly scheduled Pap tests are vitally important in the detection of cervical cancer and routine testing should continue based upon established screening intervals.
Approved by the ASC Executive Board, March, 2007
|
HPV Resources can be found here |
Journal of the American Society of Cytopathology
(JASC)
Get Social
Annual Scientific Meeting News
Education Center
About The ASC
Marketplace
CytoJobs
Search or post career opportunities